Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Children’s Healthcare of Atlanta’s heart clinics treat about 200 children a year. This includes Audrey Koch, a Roswell teen with a heart condition called Long QT syndrome.

Current clinical tools rely on known cardiovascular risk elements, but they often do not account for complex interactions ...

Background and objective: Prolonged QTc interval on admission and a higher risk of death in SARS-CoV-2 patients have been reported. The long-term clinical impact of prolonged QTc interval is unknown.

Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

QTc Interval Prolongation: XOLREMDI causes concentration-dependent QTc prolongation. QTc prolongation may occur when XOLREMDI is taken with concomitant medications that increase XOLREMDI exposure ...

With so many loyalty programs available, it can be challenging to determine which ones truly add value. That's why Newsweek ...

However, the relationship between IGFs and IGFBP-3 with the QTc interval in humans, is unknown. Objectives: To examine the association of IGFs and IGFBP-3 with QTc interval in an older age ...

Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...

The project involves extracting and analyzing genetic variants from the ClinVar database and processing ECG signals to calculate QT intervals. Genotype Data Analysis The main outcome of this part was ...

Brittney Hoffman, 31, picked up a new prescription last year to treat ADHD symptoms, but initially was confused about the ...